CIK 0001655759
- Accelerated filer
ARVINAS, INC.
Sign in to watch- Ticker
- ARVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472566120
- Phone
- +1 203-535-1456
- Business address
- 395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT, 06511
- Former names
- ARVINAS INC., ARVINAS HOLDING COMPANY, LLC
- 4 Grant or award Director acquired 16,025 shares (grant or award)
- 4 Grant or award Director acquired 16,025 shares (grant or award)
- 4 Grant or award Director acquired 16,025 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 5,700 shares at $7.61 ($43,377)
- 4 Open-market sale Chief Scientific Officer sold 2,583 shares at $7.49 ($19,347)
- 4 Grant or award Chief Accounting Officer acquired 11,825 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 59,600 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 59,600 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 59,600 shares (grant or award)
- 4 Open-market sale Chief Medical Officer sold 8,658 shares at $8.59 ($74,372)
- 4 Open-market sale Chief Accounting Officer sold 1,214 shares at $16.75 ($20,335)
- 4 Open-market sale Chief Scientific Officer sold 4,207 shares at an average $16.70 ($70,238)
- 4 Open-market sale President, R&D sold 9,020 shares at an average $16.71 ($150,752)
- 4 Open-market sale President and CEO sold 31,338 shares at an average $16.72 ($523,881)
- 4 Grant or award Chief Accounting Officer acquired 10,584 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 49,092 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 20,619 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 55,229 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 49,092 shares (grant or award)
- 4 Grant or award President and CEO acquired 152,000 shares (grant or award)
Page 3 of 15 · 285 filings